ICNA President-Elect Elections 2024 are currently underway. All eligible voters (ICNA Full Members) have been emailed their unique voting credentials. All voting is done via the secure platform at https://icnapedia.org/pe2024. The voting site will remain open until 2400hrs GMT on 1 May 2024.
Write a comment
| 6 - 6:30 AM | 6:30 - 7 AM | 7 - 7:30 AM | 7:30 - 8 AM | 8 - 8:30 AM | 8:30 - 9 AM | 9-9:30 AM | 9:30 - 10 AM | 10 - 10:30 AM | 10:30 - 11 AM | 11 - 11:30 AM | 11:30 - 12 PM | 12 - 12:30 PM | 12:30 - 1 PM | 1 - 1:30 PM | 1:30 - 2 PM | 2 - 2:30 PM | 2:30 - 3 PM | 3 - 3:30 PM | 3:30 - 4 PM | 4 - 4:30 PM | 4:30 - 5 PM | 5 - 5:30 PM | 5:30 - 6 PM | 6 - 6:30 PM | 6:30 - 7 PM | 7 - 7:30 PM | 7:30 - 8 PM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MONDAY, OCTOBER 12 | |||||||||||||||||||||||||||
| SIG Option #1 | SIG Option #3 | SIG Option #5 | |||||||||||||||||||||||||
| SIG Option #2 | SIG Option #4 | SIG Option #6 | |||||||||||||||||||||||||
| TUESDAY, OCTOBER 13 | |||||||||||||||||||||||||||
| Meet the Experts: Experimental Therapeutics; Gene Therapy for Childhood Neurological Disorders | |||||||||||||||||||||||||||
| SIG Option #7 | SIG Option #9 | SIG Option #11 | |||||||||||||||||||||||||
| Workshop: Neuropsychiatry/Movement Disorders: Practical Management of Functional Neurologic Diseases in Children | |||||||||||||||||||||||||||
| SIG Option #8 | SIG Option #10 | ||||||||||||||||||||||||||
| Meet the Experts: Ethics: Costly Drugs and Healthcare —Ethics and Value Perspectives from Different Healthcare Systems | |||||||||||||||||||||||||||
| Meet the Experts: Neuroimmunology: Parainfections and Seronegative Autoimmune Encephalitis in Children: Updates and Controversies | |||||||||||||||||||||||||||
| Seminar 1: Epilepsy: Don't Ask Don't Tell, or Full Disclosure? Discussing SUDEP with Patients and Families in the Global Community | |||||||||||||||||||||||||||
| WEDNESDAY, OCTOBER 14 | |||||||||||||||||||||||||||
| Seminar 2: Neuroinfectious Disease: Measles Vaccination - Current Situation and Consequences - A Global Perspective | |||||||||||||||||||||||||||
| EXHIBITS | |||||||||||||||||||||||||||
| SIG Option #12 | SIG Option #14 | SIG Option #16 | |||||||||||||||||||||||||
| Seminar 3: Neurogenetics: Recent Advances in the Etiologies and Mechanisms Underlying Common Brain Malformations | |||||||||||||||||||||||||||
| SIG Option #13 | SIG Option #15 | SIG Option #17 | |||||||||||||||||||||||||
| Seminar 4: Neuroimmunology: A New Era for Patients with NMOSD, including Children | |||||||||||||||||||||||||||
| Seminar 5: Stroke: Pediatric Stroke in the Era of Advanced Genetics | |||||||||||||||||||||||||||
| Junior Member Session 1: Becoming a Physician Scientist in Pediatric Neurology | |||||||||||||||||||||||||||
| THURSDAY, OCTOBER 15 | |||||||||||||||||||||||||||
| Workshop: Epilepsy: Pediatric Epilepsy Surgery: When, by Whom, and What to Expect? | |||||||||||||||||||||||||||
| EXHIBITS | |||||||||||||||||||||||||||
| SIG Option #18 | SIG Option #20 | SIG Option #22 | |||||||||||||||||||||||||
| Workshop: Global Neurology: Training to Bridge the Gap in Global Access to Child Neurology Care | |||||||||||||||||||||||||||
| SIG Option #19 | SIG Option #21 | SIG Option #23 | |||||||||||||||||||||||||
| Junior Member Session 2: Nurturing the Global Pipeline of Academic Child Neurologists | |||||||||||||||||||||||||||
| Meet the Experts: Behavioral Neurology: Management of Behavior in Children with Neurodevelopmental Disorders | |||||||||||||||||||||||||||
| FRIDAY, OCTOBER 16 | |||||||||||||||||||||||||||
| Meet the Experts: Neuro-Cutaneous Disorders (In spanish): Neurocutaneous Syndrome Iberoamerican Network | |||||||||||||||||||||||||||
| SIG Option #24 | SIG Option #26 | ||||||||||||||||||||||||||
| Seminar 6: Headache (In spanish): Migraine in Children and Adolescents- Diagnosis, Management and Treatment | |||||||||||||||||||||||||||
| SIG Option #25 | SIG Option #27 | ||||||||||||||||||||||||||
| Seminar 7: NeuroinflammationL: Interferonopathies | |||||||||||||||||||||||||||
| Seminar 8: Neonatal Neurology: The Value of Magnetic Resonance Imaging in the Newborn | |||||||||||||||||||||||||||
| Meet the Experts: Neuromuscular: The Many Faces of Pediatric Neuromuscular Diseases: Cases, Approaches, Pearls and Challenges | |||||||||||||||||||||||||||
| Workshop: Epilepsy/General Child Neurology: Telehealth- A Means to Global Outreach | |||||||||||||||||||||||||||
| Junior Member Session 3: International Clinical Research Consortia in Child Neurology: Get Involved! | |||||||||||||||||||||||||||
| Child Neurology Foundation: Shortening the Diagnostic Odyssey | |||||||||||||||||||||||||||
| Meet the Experts: Movement Disorders: Tics, Stereotypies, and their Look-a-Likes – Understanding and Managing Repetitive Movements | |||||||||||||||||||||||||||
| MONDAY, OCTOBER 19 | |||||||||||||||||||||||||||
| Neurobiology of Disease in Children Symposium: Traumatic Brain Injury (TBI) | |||||||||||||||||||||||||||
| SIG Option #28 | SIG Option #29 | ||||||||||||||||||||||||||
| SIG Option #30 | |||||||||||||||||||||||||||
| TUESDAY, OCTOBER 20 | |||||||||||||||||||||||||||
| JOHN STOBO PRITCHARD AWARD LECTURE: Nicola Specchio, MD, PhD, Bambino Gesu' Children's Hospital, IRCCS, Rome, Italy: Developmental and Epileptic Encephalopathies: What we know and what we do not know | |||||||||||||||||||||||||||
| BERNARD SACHS AWARD LECTURE: Joseph G. Gleeson, MD; University of California San Diego, Rady Children’s Institute for Genomic Medicine, San Diego, CA, USA: Genes as a Window into the Developing Brain | |||||||||||||||||||||||||||
| Exhibits | |||||||||||||||||||||||||||
| SYMPOSIUM 1: NEUROIMMUNOLOGY: International Consensus Opinions in Opsoclonus-Myoclonus-Ataxia Syndrome | |||||||||||||||||||||||||||
| SYMPOSIUM 2: STROKE: Pediatric Stroke: Hot Topics, Global Challenges | |||||||||||||||||||||||||||
| SYMPOSIUM 3: EPILEPSY: Infantile Spasms - Current Management -A Global Perspective; The Way Forward | |||||||||||||||||||||||||||
| SYMPOSIUM 4: NEURO-ONCOLOGY: Pediatric Mixed Neuronal-Glial Tumors: New Classifications, Molecular Understandings and Targeted Therapy | |||||||||||||||||||||||||||
| SYMPOSIUM 5: NEUROMUSCULAR DISEASE: Advances in Pediatric Charcot-Marie-Tooth Disease | |||||||||||||||||||||||||||
| SYMPOSIUM 6: NEONATAL SEIZURES: Practical Approaches to Classification, Diagnosis and Management | |||||||||||||||||||||||||||
| WEDNESDAY, OCTOBER 21 | |||||||||||||||||||||||||||
| SHEILA WALLACE AWARD LECTURE: Suvasini Sharma, MD, DM; Lady Hardinge Medical College and Associated Kalawati Saran Children’s Hospital, New Delhi, India: Dietary Therapies for Epilepsy in Low Resource Settings: Challenges and Successes | |||||||||||||||||||||||||||
| PHILIP R. DODGE YOUNG INVESTIGATOR AWARD LECTURE: Hsiao-Tuan Chao, MD, PhD; Baylor College of Medicine, Houston, TX, USA: The Impact of Serendipity: From "Rare" Neurodevelopmental Disorders to Common Insights | |||||||||||||||||||||||||||
| Exhibits | |||||||||||||||||||||||||||
| SYMPOSIUM 9: NEUROGENETICS: Current Status of Developmental Encephalopathies: Rett syndrome, MECP2 Duplication Disorder, CDKL5 Deficiency Disorder, and FOXG1 Disorder | |||||||||||||||||||||||||||
| SYMPOSIUM 10: NEUROIMMUNOLOGY: Cutting Edge Technology in Neuroinflammation: Advancing Science and Increasing Capacity in Low and Middle-income Countries | |||||||||||||||||||||||||||
| SYMPOSIUM 11: COGNITIVE-BEHAVIORAL NEUROLOGY: The Molecular & Cellular Basis of Developmental Cognitive & Behavioral Disorders | |||||||||||||||||||||||||||
| SYMPOSIUM 12: SLEEP: Integrating Pediatric Sleep Medicine into Child Neurology | |||||||||||||||||||||||||||
| SYMPOSIUM 13: CEREBRAL PALSY: An Open Discussion on the Definition of Cerebral Palsy | |||||||||||||||||||||||||||
| SYMPOSIUM 14: EPILEPSY: Epilepsy and Psychiatric Comorbidities | |||||||||||||||||||||||||||
| SYMPOSIUM 15: GLOBAL NEUROLOGY: Global Challenges and Opportunities in Inpatient Child Neurology | |||||||||||||||||||||||||||
| SYMPOSIUM 16: EPILEPSY: Ketogenic Diets in Child Neurology – A Tale of 100 Years: What Does the Future Hold? | |||||||||||||||||||||||||||
| THURSDAY, OCTOBER 22 | |||||||||||||||||||||||||||
| LINDA DE MEIRLEIR NEUROMETABOLIC AWARD: Lance Rodan, MD, FRCP(C); Boston Children's Hospital, Harvard Medical School, Boston, MA, USA: Update in Pediatric Neurometabolic Disorders 2020 | |||||||||||||||||||||||||||
| HOWER AWARD LECTURE: Kenneth J. Mack, MD, PhD; Mayo Clinic, Rochester, MN, USA: Migraine, Vertigo, and Dizziness | |||||||||||||||||||||||||||
| SYMPOSIUM 17: NEONATAL NEUROLOGY: Neurodevelopmental Outcomes in Congenital Heart Disease: From Fetal Pathogenesis to Prevention | |||||||||||||||||||||||||||
| SYMPOSIUM 18: NEURODEVELOPMENTAL DISORDERS: IN SPANISH: Beyond Pharmacological Treatment for Neurodevelopmental Disorders: What Parents and Physicians Want to Know About the Available Options | |||||||||||||||||||||||||||
| SYMPOSIUM 19: ETHICS: Humanism in Child Neurology: The Time is Now! |
|||||||||||||||||||||||||||
| SYMPOSIUM 20: HEADACHE: Migraine Management in 2020: New Options for Treatment and How to Incorporate Recent Guidelines and Novel Treatments in Clinical Practice | |||||||||||||||||||||||||||
| SYMPOSIUM 21: NEUROMUSCULAR DISEASE: Gene Transfer for Children: What we Know Now | |||||||||||||||||||||||||||
| SYMPOSIUM 22: EPILEPSY: IN SPANISH: Pediatric Epilepsy. When Drugs Don’t Work | |||||||||||||||||||||||||||
| SYMPOSIUM 23: NEURO-METABOLIC DISORDERS: Vitamin Responsive Conditions in Child Neurology: Whats New? | |||||||||||||||||||||||||||
| SYMPOSIUM 24: GLOBAL NEUROLOGY: Pediatric Neurology. A Global Perspective | |||||||||||||||||||||||||||
| FRIDAY, OCTOBER 23 | |||||||||||||||||||||||||||
| FRANK FORD AWARD LECTURE: Charles Newton, MD; University of Oxford, Oxford, United Kingdom, KEMRI-Wellcome Trust Collaborative Programme, Kilifi, Kenya: The Global Burden of Paediatric Neurological Disorders | |||||||||||||||||||||||||||
| SYMPOSIUM 25: TRAUMATIC BRAIN INJURY: New Advances in Management, Treatment and Rehabilitation | |||||||||||||||||||||||||||
| SYMPOSIUM 26: NEUROMETABOLIC DISORDERS: Novel Advanced Treatment in Neurogenetic Disorders | |||||||||||||||||||||||||||
| SYMPOSIUM 27: NEUROIMMUNOLOGY: MOG Antibody Associated Neurological Disease – An Update for the Clinician | |||||||||||||||||||||||||||
| SYMPOSIUM 28: GLOBAL NEUROLOGY: Integration of Global Health and Child Neurology: Perspectives and Successful Partnerships Around the World |
|||||||||||||||||||||||||||
Be the first to comment.